Home > News > BASF Venture Capital invests in North American investment fund ARCH Venture Fund VII
December 12th, 2007
BASF Venture Capital invests in North American investment fund ARCH Venture Fund VII
BASF Venture Capital America Inc., Fremont, CA, has invested in ARCH Venture Fund VII - a venture capital fund managed by ARCH Venture Partners, Chicago, IL. ARCH invests at a very early stage in start-up companies from the material science, life science, as well as information technology and biotechnology sectors in North America. The majority of these start-ups have been spun off from universities or national research laboratories. The total volume of the ARCH fund will be roughly $400 million fund. BASF Venture Capital will invest $5 million. Other investors in the fund are primarily universities, pension funds and financial institutions.
"ARCH is one of the most-respected venture capital funds in the U.S., supported by an impressive management team. ARCH will complement our strategy of investing in innovative companies that are active in BASF Group's five growth clusters - energy management, raw material change, nanotechnology plant biotechnology and white (industrial) biotechnology," said Keith Gillard, Principal of BASF Venture Capital America.
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014
7th Nanotechnology Festival, Exhibition Kicks Off Work in Iran October 7th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
First Observation of Electronic Structure in Ag-Rh Alloy Nanoparticles Having Hydrogen Absorbing: Storage Property –Attempting to solve the mystery of why Ag-Rh alloy nanoparticles have a similar property to Pd– October 30th, 2014
Iranians Present Model to Predict Photocatalytic Process in Removal of Pollutants October 30th, 2014
Production of Biocompatible Polymers in Iran October 30th, 2014
Amorphous Coordination Polymer Particles as alternative to classical nanoplatforms for nanomedicine October 30th, 2014